We previously demonstrated that SK1 is highly expressed in FMC, and high levels of SK1 correlated with poor prognosis of FMC [24], in line with the notion that overexpression of SK1 in human triple-negative breast cancer is associated with an unfavorable disease outcome [19]. This evidence concerns the gene SPHK1 and triple-negative breast carcinoma.